El-Hibri Fuad 4
4 · Aptevo Therapeutics Inc. · Filed Feb 17, 2021
Insider Transaction Report
Form 4
El-Hibri Fuad
Director
Transactions
- Award
Stock Option (right to buy)
2020-07-02+3,571→ 3,571 totalExercise: $9.18Exp: 2030-07-02→ Common Stock (3,571 underlying)
Footnotes (1)
- [F1]The option vests in three approximately equal annual installments beginning on July 2, 2021.